Michael R Buchanan

Title: Michael R Buchanan - Innovator in Thrombin Inhibition

Introduction

Michael R Buchanan is a notable inventor based in Hamilton, CA. He has made significant contributions to the field of biochemistry, particularly in the area of thrombin inhibition. His innovative work has led to the development of a unique method that has potential applications in medical treatments.

Latest Patents

Michael R Buchanan holds a patent for "Dermatan disulfate, an inhibitor of thrombin generation and activation." This patent describes a method of inhibiting thrombin generation and complement activation by utilizing a dermatan sulfate that has at least two sulfate groups per disaccharide. The dermatan sulfate is obtained through the chemical sulfation of native dermatan sulfate. The resulting compound has an average molecular weight ranging from about 5000 to 35000 Daltons. It is characterized by a high content of L-iduronic->4,6-di-O-sulfated N-acetyl-D-galactosamine residues and exhibits specific heparin cofactor II-mediated anti-thrombin activity, which varies between about 25 to 125 U/mg depending on the average molecular weight.

Career Highlights

Throughout his career, Michael R Buchanan has focused on advancing the understanding of thrombin and its implications in various medical conditions. His research has contributed to the development of therapeutic strategies aimed at managing thrombin-related disorders.

Collaborations

Michael has collaborated with esteemed colleagues in his field, including Stephanie J Brister and Robert J Linhardt. These collaborations have further enriched his research and have led to advancements in the understanding of thrombin inhibition.

Conclusion

Michael R Buchanan is a distinguished inventor whose work in thrombin inhibition has the potential to impact medical treatments significantly. His innovative patent showcases his dedication to advancing biochemistry and improving health outcomes.